Company overview
Basic information
Company name
Jomanto parkas, UAB
Company code
305438895
VAT code
LT100012953915
Registered address
Vilnius, Kintų g. 11, LT-09301
Registration date
2020-01-27
Company age: 6 y. 9 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Development of building projects
Ownership form
Private without foreign capital
UAB "Jomanto parkas"
Company code: 305438895
Address: Vilnius, Kintų g. 11, LT-09301
VAT code: LT100012953915
Description
This description was generated by artificial intelligence.
Jomanto parkas, UAB (company code 305438895) is an operational private limited liability company registered in 2020. It is classified as a small private non-financial company with private ownership, meaning Lithuanian natural and legal persons hold more than 50% of the authorised capital and there is no foreign investor capital. Governance is CEO only. The company is located in Vilnius, Kintu g. 11, Vilniaus m. sav., Vilniaus apskr. Its main activity is EVRK M.68.12.00, Development of building projects. Share capital amounts to EUR 7.41 million. Financially, the company reported revenue of EUR 39.0 thousand in 2025, following EUR 3.61 million in 2024 and EUR 21.45 million in 2023. It remained profitable, posting net profit of EUR 272.0 thousand in 2025 after EUR 654.0 thousand in 2024 and EUR 2.97 million in 2023. At the end of 2025, equity stood at EUR 7.89 million and total assets at EUR 7.99 million, with liabilities of EUR 100.0 thousand. The company averaged 1 employee in 2025 and so far in 2026.
Download a detailed company report
Make confident decisions with all the information about Jomanto parkas, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.